06.04.2010 • News

Airgas Rejects Air Products' Tender Extension

Airgas on Thursday repeated its view that a $5.1 billion hostile bid by Air ProductsAir "grossly undervalues" the company, after larger rival Air Products earlier extended its tender offer for Airgas.

Air Products said its $60-per-share offer to Airgas will now expire at midnight on June 4. As of Thursday, about 12,291 shares of Airgas stock had been tendered, according to the statement from Air Products.

The Air Products' offer, made in February, was originally due to expire on April 9.

From Catalogue to Collaboration

Enamine's Expert Insights Collection Is Free to Download
Enamine’s 35 Years of Advancing Drug Discovery

Enamine's Expert Insights Collection Is Free to Download

From catalogue to collaboration — explore 35 years of drug discovery breakthroughs, novel building blocks, and the science shaping tomorrow's medicines. Download your complimentary copy now.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Top-Feature

most read

Photo
News • Chemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.